Page last updated: 2024-10-16

butyric acid and Hypereosinophilic Syndrome

butyric acid has been researched along with Hypereosinophilic Syndrome in 4 studies

Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.

Hypereosinophilic Syndrome: A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of EOSINOPHILS in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.

Research Excerpts

ExcerptRelevanceReference
"A human eosinophilic leukemia cell line, EoL-1, stopped proliferating at the G1 phase, differentiated into eosinophilic granule-containing cells, and died by apoptosis when stimulated with dibutyryl cyclic AMP (dbcAMP)."1.29Different effects of cyclic AMP and butyrate on eosinophilic differentiation, apoptosis and bcl-2 expression of a human eosinophilic leukemia cell line, EoL-1. ( Eun-Young, J; Kenji, K; Kenshi, F; Masahiko, K; Mitsufumi, M; Tai, G; Toshio, H; Yuji, H, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, JS1
Kim, IS1
Izumi, T1
Kishimoto, S1
Takano, T1
Nakamura, M1
Miyabe, Y1
Nakata, M1
Sakanaka, C1
Shimizu, T1
Tai, G1
Eun-Young, J1
Yuji, H1
Masahiko, K1
Toshio, H1
Kenji, K1
Kenshi, F1
Mitsufumi, M1
Wang, W1
Tanaka, T1
Okamura, H1
Sugita, M1
Higa, S1
Kishimoto, T1
Suemura, M1

Other Studies

4 other studies available for butyric acid and Hypereosinophilic Syndrome

ArticleYear
Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation.
    Molecular biology reports, 2010, Volume: 37, Issue:5

    Topics: Butyric Acid; Cell Differentiation; Cell Line, Tumor; Cell Movement; Chemokines, CC; Enzyme Activati

2010
Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation.
    The Biochemical journal, 1995, Feb-01, Volume: 305 ( Pt 3)

    Topics: Amino Acid Sequence; Animals; Azepines; Base Sequence; Butyrates; Butyric Acid; Cell Differentiation

1995
Different effects of cyclic AMP and butyrate on eosinophilic differentiation, apoptosis and bcl-2 expression of a human eosinophilic leukemia cell line, EoL-1.
    Hematological oncology, 1996, Volume: 14, Issue:4

    Topics: Apoptosis; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Colforsin; Dinoprostone; Drug

1996
Interleukin-18 enhances the production of interleukin-8 by eosinophils.
    European journal of immunology, 2001, Volume: 31, Issue:4

    Topics: Butyric Acid; Cell Differentiation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug

2001